Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Uric acid in multiple sclerosis.

Marcus Koch1, Jacques De Keyser

  • 1Department of Neurology, University Medical Centre Groningen, University of Groningen, The Netherlands.

Neurological Research
|May 12, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Pivotal Step of Structure Formation and Oil-Binding Capacity of Polyglucosamine.

Polymer science & technology (Washington, D.C.)·2026
Same author

Extracellular vesicles derived from Enterococcus faecalis: inflammatory activation does not require internalization.

Cell communication and signaling : CCS·2026
Same author

A multivalent TAT-arginine-biodynamer conjugate targeting the bacterial cell envelope via specific membrane interactions.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Diminishing returns of disease-modifying treatment in older participants of multiple sclerosis clinical trials.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Design of Poly-Catechol Biodynamers for Potentiation of Antibiotic Efficacy against Drug-Resistant Bacteria.

Biomacromolecules·2026
Same author

Extracellular vesicles and their RNA cargo facilitate bidirectional cross-kingdom communication between human and bacterial cells.

Gut microbes·2026

Lower uric acid levels in multiple sclerosis (MS) patients may reflect disease activity, as uric acid scavenges harmful peroxynitrite. Monitoring uric acid could help track MS progression and inform neuroprotective therapies.

Area of Science:

  • Neuroimmunology
  • Oxidative Stress Research
  • Biomarker Discovery

Background:

  • Peroxynitrite, a pro-inflammatory oxidant in multiple sclerosis (MS), causes tissue damage.
  • Uric acid naturally scavenges peroxynitrite and reduces demyelination in experimental models.
  • Conflicting reports exist on serum uric acid levels in MS patients.

Purpose of the Study:

  • To critically appraise the role of uric acid in multiple sclerosis.
  • To investigate uric acid as a potential biomarker for MS disease activity.
  • To explore the neuroprotective potential of uric acid-based therapies in MS.

Main Methods:

  • Critical appraisal of existing studies on uric acid and MS.
  • Analysis of the relationship between peroxynitrite scavenging and uric acid levels.

Related Experiment Videos

  • Evaluation of therapeutic implications for managing MS.

    • Main Results:

    • Reduced serum uric acid in MS is likely secondary to its activity in scavenging peroxynitrite during inflammation.
    • Uric acid levels may serve as a biomarker for monitoring MS disease activity.
    • Therapeutic interventions to increase uric acid may offer glial and neuroprotection.

    Conclusions:

    • Uric acid's role in MS is primarily as a scavenger of inflammatory oxidants.
    • Serum uric acid levels show promise as a biomarker for MS disease activity.
    • Strategies to elevate uric acid could be beneficial for MS patient neuroprotection.